Akorn Inc Quick Ratio (AKRXQ) starting from the second quarter 2020 to second quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Akorn Inc  (AKRXQ)

Akorn Inc's Quick Ratio

AKRXQ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Akorn Inc's Cash & cash equivalent grew by 15.17 % in the Q2 2020 sequentially, faster than Current Liabilities, this led to improvement in Akorn Inc's Quick Ratio to 0.08, Quick Ratio remained below Akorn Inc average.

Within Major Pharmaceutical Preparations industry 477 other companies have achieved higher Quick Ratio than Akorn Inc in second quarter 2020. While Quick Ratio total ranking has improved so far during the Q2 2020 to 4423, from total ranking in the first quarter 2020 at 4463.

Explain Quick Ratio?
How much Cash & cash equivalents AKRXQ´s has?
What are AKRXQ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKRXQ Quick Ratio (Jun 30 2020)
Q2		 (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2
Y / Y Current Liabilities Change -4.04 % 483.94 % 396.1 % 427.54 % 478.86 %
Y / Y Cash & cash equivalent Change -53.37 % -60.79 % -35.6 % -25.35 % -39.93 %
Quick Ratio MRQ 0.08 0.07 0.15 0.2 0.17
AKRXQ's Total Ranking # 4423 # 4463 # 4100 # 3863 # 3982
Seq. Current Liabilities Change 0.45 % -0.77 % -2.23 % -1.53 % 511.25 %
Seq. Cash & cash equivalent Change 15.17 % -50.15 % -29.55 % 15.3 % -3.16 %



Quick Ratio second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 478
Healthcare Sector # 925
Overall Market # 4423


Quick Ratio Statistics
High Average Low
2.97 1.17 0.07
(Dec 31 2011)   (Mar 31 2020)




Financial Statements
Akorn Inc's Current Liabilities $ 990 Millions Visit AKRXQ's Balance sheet
Akorn Inc's Cash & cash equivalent $ 83 Millions Visit AKRXQ's Balance sheet
Source of AKRXQ's Sales Visit AKRXQ's Sales by Geography


Cumulative Akorn Inc's Quick Ratio

AKRXQ's Quick Ratio for the trailling 12 Months

AKRXQ Quick Ratio

 (Jun 30 2020)
12 Months		 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months
Y / Y Current Liabilities TTM Growth 150.1 % 444.26 % 343.97 % 264.57 % 143.77 %
Y / Y Cash & cash equivalent TTM Growth -41.38 % -38.76 % -35.58 % -36.56 % -34.64 %
Quick Ratio TTM 0.13 0.15 0.22 0.33 0.54
Total Ranking TTM # 4736 # 3659 # 4623 # 4534 # 4549
Seq. Current Liabilities TTM Growth -1.04 % 25.45 % 32.82 % 51.68 % 115.37 %
Seq. Cash & cash equivalent TTM Growth -15.83 % -15.7 % -10.1 % -8.09 % -12.08 %

Quick ratio ranking by company, industry and sector >> Back to AKRXQ Financial Strength Comparisons >> Go to Compare AKRXQ Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in AKRXQ's Current Liabilities to $990.01 millions, cumulative Quick Ratio to 0.13 below the AKRXQ average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 483 other companies have achieved higher Quick Ratio than Akorn Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2020 from 3659 to 4736.

Explain Quick Ratio?
How much Cash & cash equivalents AKRXQ´s has?
What are AKRXQ´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 484
Healthcare Sector # 941
Within the Market # 4736


trailing twelve months Quick Ratio Statistics
High Average Low
2.12 1.13 0.13
(Mar 31 2018)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2020, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2020 MRQ Cash & cash equivalentJun 30 2020 MRQ Current Liabilities
Gelesis Holdings Inc   0.23 $ 0.032  Millions$ 0.140  Millions
Medicure Inc   0.22 $ 2.080  Millions$ 9.430  Millions
Serina Therapeutics Inc   0.22 $ 1.033  Millions$ 4.713  Millions
Health right Discoveries Inc   0.21 $ 2.009  Millions$ 9.696  Millions
Teva Pharmaceutical Industries Limited  0.20 $ 2,402.000  Millions$ 11,751.000  Millions
China Pharma Holdings Inc  0.20 $ 1.814  Millions$ 9.224  Millions
Astrazeneca Plc  0.19 $ 5,673.000  Millions$ 29,166.000  Millions
Novartis Ag  0.19 $ 6,225.000  Millions$ 33,059.000  Millions
Enveric Biosciences Inc   0.16 $ 2.088  Millions$ 12.769  Millions
Sunshine Biopharma Inc   0.15 $ 0.093  Millions$ 0.603  Millions
Gsk Plc  0.14 $ 8,596.130  Millions$ 61,966.733  Millions
Rapid Therapeutic Science Laboratories Inc   0.14 $ 0.213  Millions$ 1.555  Millions
Gridai Technologies Corp  0.13 $ 1.021  Millions$ 7.616  Millions
Reshape Lifesciences Inc  0.13 $ 1.526  Millions$ 11.729  Millions
Point Biopharma Global Inc   0.13 $ 0.065  Millions$ 0.509  Millions
Jaguar Health Inc   0.12 $ 3.015  Millions$ 24.758  Millions
One World Products Inc   0.10 $ 0.173  Millions$ 1.682  Millions
Zevra Therapeutics Inc   0.09 $ 6.369  Millions$ 72.240  Millions
Akorn Inc  0.08 $ 83.130  Millions$ 990.012  Millions
Oncotelic Therapeutics Inc   0.08 $ 0.661  Millions$ 8.217  Millions
Opko Health Inc   0.08 $ 21.612  Millions$ 279.543  Millions
Neuropathix Inc.  0.08 $ 0.166  Millions$ 2.185  Millions
American Bio Medica Corporation  0.07 $ 0.225  Millions$ 3.135  Millions
Vaccinex Inc   0.07 $ 0.526  Millions$ 7.543  Millions
Northwest Biotherapeutics Inc  0.07 $ 5.955  Millions$ 88.570  Millions
Sunwin Stevia International Inc.  0.05 $ 0.876  Millions$ 16.434  Millions
Nuvation Bio Inc   0.05 $ 0.003  Millions$ 0.066  Millions
Provectus Biopharmaceuticals Inc   0.05 $ 1.483  Millions$ 29.190  Millions
Mylan N v   0.05 $ 323.600  Millions$ 6,971.300  Millions
Wellness Center Usa Inc  0.04 $ 0.094  Millions$ 2.316  Millions

Date modified: 2026-09-08T15:10:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.